| Date Filed | Type | Description |
| 08/09/2023 |
4
| Washburn Theodore James Jr. (Principal Accounting Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Sold 2,918 shares
@ $25.3927, valued at
$74.1k
|
|
| 08/02/2023 |
4
| Washburn Theodore James Jr. (Principal Accounting Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Sold 1,232 shares
@ $26.26, valued at
$32.4k
Exercised 4,150 restricted stock units
@ $0 |
|
| 03/07/2023 |
4
| Washburn Theodore James Jr. (Principal Accounting Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Sold 504 shares
@ $24.29, valued at
$12.2k
|
|
| 02/14/2023 |
4
| Washburn Theodore James Jr. (Principal Accounting Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 273 shares
@ $28.44, valued at
$7.8k
Granted 6,896 restricted stock units
@ $0
Exercised 777 restricted stock units
@ $0 |
|
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2022 |
4
| Washburn Theodore James Jr. (Principal Accounting Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Sold 233 shares
@ $30.81, valued at
$7.2k
|
|
| 02/16/2022 |
4
| Washburn Theodore James Jr. (Principal Accounting Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 127 shares
@ $30.5, valued at
$3.9k
Sold 504 shares
@ $31.25, valued at
$15.8k
Exercised 360 restricted stock units
@ $0 |
|
| 02/14/2022 |
4
| Washburn Theodore James Jr. (Principal Accounting Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 273 shares
@ $31.425, valued at
$8.6k
Exercised 777 restricted stock units
@ $0 |
|
| 08/05/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |